MYDA Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

MYDA Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-35,000	Closed	-$120K	–	349
2021 Q1	$120K	Buy	+35,000	New	+$109K	0.03%	268

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCA

VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MYDA Advisors's ENZ Position: Q2 2021 in Review

MYDA Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 35,000 shares — an estimated $120K sold.

MYDA Advisors first reported a position in ENZ in Q1 2021 and held it in 1 quarter. The position peaked at $120K in Q1 2021. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.

MYDA Advisors reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
MYDA Advisors sold 35,000 Enzo Biochem, Inc. shares in Q2 2021, an estimated $120K.
MYDA Advisors first reported a position in Enzo Biochem, Inc. in Q1 2021 and held it in 1 quarter.
MYDA Advisors's Enzo Biochem, Inc. position peaked at $120K in Q1 2021.
72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.

Based on MYDA Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.